Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (32)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Spalding, J. W.
Right arrow Articles by Tennant, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spalding, J. W.
Right arrow Articles by Tennant, R. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences, Vol 49, 241-254, Copyright © 1999 by Society of Toxicology

ARTICLES

Development of a transgenic mouse model for carcinogenesis bioassays: evaluation of chemically induced skin tumors in Tg.AC mice

JW Spalding, JE French, RR Tice, M Furedi-Machacek, JK Haseman and RW Tennant
Laboratory of Environmental Carcinogenesis and Mutagenesis, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA. spalding@niehs.nih.gov

Transgenic rodent models have emerged as potentially useful tools in the assessment of drug and chemical safety. The transgenic Tg.AC mouse carries an inducible v-Ha-ras oncogene that imparts the characteristic of genetically initiated skin to these animals. The induction of epidermal papillomas in the area of topically applied chemical agents, for duration of not more than 26 weeks, acts as a reporter phenotype that defines the activity of the test article. We describe here the activity of six chemicals that have been previously characterized for activity in the standard 2-year bioassay conducted by the National Toxicology Program (NTP). Homozygous female Tg.AC mice were treated with benzene (BZ), benzethonium chloride (BZTC), o-benzyl-p- chlorophenol (BCP), 2-chloroethanol (2-CE), lauric acid diethanolamine (LADA) and triethanolamine (TEA). BZ and LADA induced skin papillomas in a dose-dependent manner, while BCP induced papillomas only at the highest dose. BZTC, 2-CE, and TEA exhibited no activity. The correspondence of chemical activity in Tg.AC mice with that in the 2- year bioassay was high. A comparison of responsiveness to BZ and LADA was made between hemizygous and homozygous female Tg.AC mice. Both genotypes appear to be equally sensitive to maximum doses of active compounds. The results reported here indicate that the Tg.AC transgenic mouse model can discriminate between carcinogens and noncarcinogens and that both mutagenic and nonmutagenic chemicals can be detected. These studies provide support for the adjunctive use of the Tg.AC transgenic mouse skin tumor model in drug and chemical safety assessment and for the prediction of the carcinogenic potential of chemicals.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Toxicol PatholHome page
D. Lynch, J. Svoboda, S. Putta, H. E. J. Hofland, W. H. Chern, and L. A. Hansen
Mouse Skin Models for Carcinogenic Hazard Identification: Utilities and Challenges
Toxicol Pathol, December 1, 2007; 35(7): 853 - 864.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
A. M. Doi, J. R. Hailey, M. Hejtmancik, J. D. Toft II, M. Vallant, and R. S. Chhabra
Topical Application of Representative Multifunctional Acrylates Produced Proliferative and Inflammatory Lesions in F344/N Rats and B6C3F1 Mice, and Squamous Cell Neoplasms in Tg.AC Mice
Toxicol Pathol, October 1, 2005; 33(6): 631 - 640.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
Z. Zhang, R. Yao, J. Li, Y. Wang, C. W. Boone, R. A. Lubet, and M. You
Induction of Invasive Mouse Skin Carcinomas in Transgenic Mice with Mutations in Both H-ras and p53
Mol. Cancer Res., October 1, 2005; 3(10): 563 - 574.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
K. L. Thompson and F. D. Sistare
Selection of Drugs to Test the Specificity of the Tg.AC Assay by Screening for Induction of the gadd153 Promoter in Vitro
Toxicol. Sci., August 1, 2003; 74(2): 260 - 270.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
S. R. Payne and C. J. Kemp
p27 Kip1 (Cdkn1b)-Deficient Mice Are Susceptible to Chemical Carcinogenesis and May Be a Useful Model for Carcinogen Screening
Toxicol Pathol, June 1, 2003; 31(4): 355 - 363.
[Abstract] [PDF]

Home page
 Toxicol PatholHome page
R. E. Stoll, S. M. Furst, J. H. Stoltz, P. D. Lilly, and J. H. Mennear
Dermal Carcinogenicity in Transgenic Mice: Effect of Vehicle on Responsiveness of Hemizygous Tg.AC Mice to Phorbol 12-Myristate 13-Acetate (TPA)
Toxicol Pathol, August 1, 2001; 29(5): 535 - 540.
[Abstract] [PDF]

Home page
 CarcinogenesisHome page
M. StJ. Battalora, J. W. Spalding, C. J. Szczesniak, J. E. Cape, R. J. Morris, C. S. Trempus, C. D. Bortner, B. M. Lee, and R. W. Tennant
Age-dependent skin tumorigenesis and transgene expression in the Tg.AC (v-Ha-ras) transgenic mouse
Carcinogenesis, April 1, 2001; 22(4): 651 - 659.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
L. N. Healy, L. J. Pluta, R.A. James, D. B. Janszen, D. Torous, J. E. French, and L. Recio
Induction and time-dependent accumulation of micronuclei in peripheral blood of transgenic p53+/- mice, Tg.AC (v-Ha-ras) and parental wild-type (C57BL/6 and FVB/N) mice exposed to benzene by inhalation
Mutagenesis, March 1, 2001; 16(2): 163 - 168.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
R. W. Tennant, S. Stasiewicz, W. C. Eastin, J. H. Mennear, and J. W. Spalding
The Tg.AC (v-Ha-ras) Transgenic Mouse: Nature of the Model
Toxicol Pathol, January 1, 2001; 29(1_suppl): 51 - 59.
[Abstract] [PDF]

Home page
 Toxicol PatholHome page
W. C. Eastin, J. H. Mennear, R. W. Tennant, R. E. Stoll, D. G. Branstetter, J. R. Bucher, B. Mccullough, R. L. Binder, J. W. Spalding, and J. F. Mahler
Tg.AC Genetically Altered Mouse: Assay Working Group Overview of Available Data
Toxicol Pathol, January 1, 2001; 29(1_suppl): 60 - 80.
[Abstract] [PDF]

Home page
 Toxicol PatholHome page
J. I. Goodman
A Perspective on Current and Future Uses of Alternative Models for Carcinogenicity Testing
Toxicol Pathol, January 1, 2001; 29(1_suppl): 173 - 176.
[Abstract] [PDF]

Home page
 Toxicol SciHome page
D. B. Dunson, J. K. Haseman, A. P. J. M. van Birgelen, S. Stasiewicz, and R. W. Tennant
Statistical Analysis of Skin Tumor Data from Tg.AC Mouse Bioassays
Toxicol. Sci., June 1, 2000; 55(2): 293 - 302.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
D. Gulezian, D. Jacobson-Kram, C. B. Mccullough, H. Olson, L. Recio, D. Robinson, R. Storer, R. Tennant, J. M. Ward, and D. A. Neumann
Review Article: Use of Transgenic Animals for Carcinogenicity Testing: Considerations and Implications for Risk Assessment
Toxicol Pathol, May 1, 2000; 28(3): 482 - 499.
[Abstract] [PDF]

Home page
 Toxicol SciHome page
J. W. Spalding, J. E. French, S. Stasiewicz, M. Furedi-Machacek, F. Conner, R. R. Tice, and R. W. Tennant
Responses of Transgenic Mouse Lines p53+/- and Tg•AC to Agents Tested in Conventional Carcinogenicity Bioassays
Toxicol. Sci., February 1, 2000; 53(2): 213 - 223.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.